QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
NASDAQ:AQB

AquaBounty Technologies - AQB Stock Forecast, Price & News

$1.40
-0.08 (-5.41%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.39
$1.50
50-Day Range
$1.43
$1.78
52-Week Range
$1.13
$4.75
Volume
902,841 shs
Average Volume
989,496 shs
Market Capitalization
$99.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

AquaBounty Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
275.0% Upside
$5.25 Price Target
Short Interest
Healthy
3.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.23mentions of AquaBounty Technologies in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$24,000 Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.35) to ($0.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

364th out of 1,124 stocks

Fishing, Hunting & Trapping Industry

1st out of 1 stocks

AQB stock logo

About AquaBounty Technologies (NASDAQ:AQB) Stock

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.

AquaBounty Technologies Stock Performance

Shares of AQB Stock opened at $1.48 on Tuesday. The company has a quick ratio of 18.16, a current ratio of 18.39 and a debt-to-equity ratio of 0.04. AquaBounty Technologies has a 52 week low of $1.13 and a 52 week high of $4.75. The firm's 50-day simple moving average is $1.58 and its two-hundred day simple moving average is $1.59.

AquaBounty Technologies (NASDAQ:AQB - Get Rating) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. AquaBounty Technologies had a negative net margin of 811.46% and a negative return on equity of 11.15%. On average, equities research analysts forecast that AquaBounty Technologies will post -0.35 earnings per share for the current year.

Receive AQB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AquaBounty Technologies and its competitors with MarketBeat's FREE daily newsletter.

AQB Stock News Headlines

AquaBounty Technologies: Q4 Earnings Insights
See More Headlines
Receive AQB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AquaBounty Technologies and its competitors with MarketBeat's FREE daily newsletter.

AQB Company Calendar

Last Earnings
8/09/2022
Today
8/16/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Fishing, hunting & trapping
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AQB
Fax
N/A
Employees
95
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.25
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$4.50
Forecasted Upside/Downside
+275.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-22,320,000.00
Net Margins
-811.46%
Pretax Margin
-811.46%

Debt

Sales & Book Value

Annual Sales
$1.17 million
Book Value
$3.01 per share

Miscellaneous

Free Float
64,995,000
Market Cap
$99.56 million
Optionable
Not Optionable
Beta
0.95

Key Executives

  • Ms. Sylvia A. Wulf (Age 64)
    CEO, Pres & Exec. Director
    Comp: $443.31k
  • Mr. David A. Frank (Age 62)
    CFO & Treasurer
    Comp: $323.63k
  • Ms. Angela M. Olsen J.D. (Age 53)
    Gen. Counsel & Corp. Sec.
    Comp: $324.04k
  • Dr. Alejandro Rojas D.V.M. (Age 60)
    Chief Operating Officer
  • Dr. Mark Walton
    Chief Technology Officer
  • Dave Conley
    Director of Communications
  • Mr. Dennis Bryant
    Director of Sales
  • Ms. Melissa Johns Daley
    Chief People Officer
  • Mr. David F. Melbourne Jr.
    Chief Commercial Officer













AQB Stock - Frequently Asked Questions

Should I buy or sell AquaBounty Technologies stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AQB shares.
View AQB analyst ratings
or view top-rated stocks.

What is AquaBounty Technologies' stock price forecast for 2022?

2 analysts have issued 12 month price targets for AquaBounty Technologies' shares. Their AQB share price forecasts range from $4.50 to $6.00. On average, they expect the company's share price to reach $5.25 in the next year. This suggests a possible upside of 275.0% from the stock's current price.
View analysts price targets for AQB
or view top-rated stocks among Wall Street analysts.

How have AQB shares performed in 2022?

AquaBounty Technologies' stock was trading at $2.10 at the beginning of the year. Since then, AQB stock has decreased by 33.3% and is now trading at $1.40.
View the best growth stocks for 2022 here
.

When is AquaBounty Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our AQB earnings forecast
.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) posted its quarterly earnings results on Tuesday, August, 9th. The company reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. AquaBounty Technologies had a negative net margin of 811.46% and a negative trailing twelve-month return on equity of 11.15%.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Epiq Partners LLC (2.15%), Millennium Management LLC (1.77%), BNP Paribas Arbitrage SA (0.92%), Renaissance Technologies LLC (0.63%), State Street Corp (0.51%) and Perkins Capital Management Inc. (0.42%). Insiders that own company stock include Alana Kirk, David A Frank, Michael K Stern, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends
.

How do I buy shares of AquaBounty Technologies?

Shares of AQB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $1.40.

How much money does AquaBounty Technologies make?

AquaBounty Technologies (NASDAQ:AQB) has a market capitalization of $99.56 million and generates $1.17 million in revenue each year. The company earns $-22,320,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The official website for the company is www.aquabounty.com. The company can be reached via phone at (978) 648-6000 or via email at investors@aquabounty.com.

This page (NASDAQ:AQB) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.